Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PolyTherics
London, England, United Kingdomprnewswire.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
PolyTherics developed proprietary polymer-based technologies for site-specific conjugation and PEGylation of therapeutic proteins, enabling improved pharmacokinetics/stability. Their platforms have been licensed by major pharma partners for use in developing next-generation biologic drugs including ADCs. After merging with Antitope in July 2013, they became part of what would become Abzena—a leading global provider of integrated solutions for biopharmaceutical development. Products using their technology were advancing toward clinical trials at time of merger but no independent clinical results are attributed solely to "PolyTherics."[1][3][4]
- Therapeutic areas
- OncologyOther
- Modalities
- Monoclonal antibodiesAntibody-drug conjugates (ADCs)VaccinesOligonucleotides[2]PEGylated proteins/peptides[1][4]
- Industry
- Drug Discovery Services
02
Partnerships
Top five pharmaceutical companies (undisclosed)Spirogen Limited collaboration on novel ADCsCritical Pharmaceuticals collaboration on sustained release systemsnumerous international biotech/pharma clients including many top industry players.[1][4]
Beyond the preview
Go deeper on PolyTherics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PolyTherics.